🇸🇬 Ogen .625 in Singapore

Ogen .625 (estrone sulphate) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Ogen .625 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Singapore

Frequently asked questions

Is Ogen .625 approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Ogen .625 in Singapore?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.